Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study

PLoS One. 2013;8(1):e53413. doi: 10.1371/journal.pone.0053413. Epub 2013 Jan 3.

Abstract

Background: There are no previous longitudinal studies on genotype-specific natural history of human papillomavirus (HPV) infections in oral mucosa of women.

Methods: In the Finnish Family HPV Study, 329 pregnant women were enrolled and followed up. HPV-genotyping of oral scrapings was performed with nested PCR and Multimetrix® test (Progen, Heidelberg, Germany). Incidence and clearance times and rates for each HPV-genotype identified in oral mucosa were determined. Predictors for incident and cleared HPV infections for species 7/9 genotypes were analyzed using Poisson regression model.

Results: Altogether, 115 baseline HPV-negative women acquired incident oral HPV infection, and 79 women cleared their infection. HPV16 and multiple HPVs most frequently caused incident infections (65% and 12%) in 13.3 and 17.1 months respectively, followed by HPV58, HPV18 and HPV6 (close to 5% each) in 11-24 months. HPV58, HPV18 and HPV66 were the most common to clear. HPV6 and HPV11 had the shortest clearance times, 4.6 months and 2.5 months, and the highest clearance rates, 225.5/1000 wmr and 400/1000 wmr, respectively. The protective factors for incident oral HPV-species 7/9 infections were 1) new pregnancy during follow-up and 2) having the same sexual partner during FU. Increased clearance was related with older age and a history of atopic reactions, whereas previous sexually transmitted disease and new pregnancy were associated with decreased clearance.

Conclusions: HPV16 was the most frequent genotype to cause an incident oral HPV-infection. Low risk HPV genotypes cleared from oral mucosa more quickly than high risk HPV genotypes. Pregnancy affected the outcome of oral HPV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Finland
  • Follow-Up Studies
  • Genes, Viral
  • Genotype
  • Human papillomavirus 16 / genetics
  • Humans
  • Incidence
  • Mouth Mucosa / virology*
  • Papillomaviridae / genetics*
  • Papillomaviridae / metabolism
  • Papillomavirus Infections / diagnosis
  • Papillomavirus Infections / metabolism*
  • Poisson Distribution
  • Polymerase Chain Reaction
  • Pregnancy
  • Pregnancy Complications, Infectious / virology
  • Sexual Behavior

Grants and funding

This work was supported by the Academy of Finland (#116438/2006, #130204/2008), Finnish Cancer Foundation, Sohlberg Foundation, Finnish Dental Society, and the Government Special Foundation (EVO) to Turku University Hospital. The funders had no role in the study design and data analysis, decision to publish, or preparation of the manuscript.